National Headlines

IPO Update: G Medical Innovations Readies U.S. IPO

| About: G Medical Innovations Holdings (GMVD)

By, IPOs, tech, alternative investments, CEO


G Medical Innovations has proposed terms for a $15 million U.S. IPO.

The company is commercializing cardiovascular monitoring technologies.

GMVD has promising technologies but the IPO is extremely high-priced; investors may wish to watch list the stock and look for a lower entry point post-IPO.

Looking for a community to discuss ideas with? IPO Edge features a chat room of like-minded investors sharing investing ideas and strategies. Start your free trial today »

Quick Take

G Medical Innovations (GMVD) has filed to raise $15 million in a U.S. IPO of its ADSs, according to an amended registration statement.

The company is commercializing cardiovascular monitoring solutions.

GMVD has begun commercializing its lead product, but the IPO appears overpriced; interested investors may wish to exercise patience and wait for a potentially lower price after the IPO.

Company & Technology

Tel Aviv, Israel-based G Medical was founded in 2014 to provide a suite of e-health software solutions and mobile monitoring devices that help clinicians increase the level of support and care while supporting preventative medicine.

Management is headed by President, CEO and Director Yacov Geva, who has been with the firm since 2014 and has previously founded LifeWatch.

G Medical has developed the Prizma Medical Smartphone Case, a phone case that allows individuals to turn their phones into medical monitors and share their information with their doctors, including:



Categories: National Headlines